Deficit states in schizophrenia and their association with the length of illness and gender

European Archives of Psychiatry and Clinical Neuroscience

Volumn 251, Issue 6, 2001, Pages 272-278

  Bottlender, Ronald ^a   Jäger, Markus ^a   Groll, Constanze ^a   Strauss, Anton ^a   Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Deficit states; Gender; Length of illness; Negative symptoms; Schizophrenia

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA;

EID: 0035709568     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007545     Document Type: Article

References (39)

1. Negative versus positive schizophrenia
2. Gender and the course of schizophrenia: Differences in treated outcomes
3. Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology
4. Foreign adaptations of the AMDP-System
5. Deficit syndromes in schizophrenic patients 15 years after their first hospitalization: Preliminary results of a follow-up study
6. Clinical correlates of the deficit syndrome of schizophrenia
7. Deficit and nondeficit forms of schizophrenia: The concept
8. Illnessduration and neuropsychological impairments in schizophrenia
9. Ventricular enlargement in poor-outcome schizophrenia
10. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
11. Structure and course of positive and negative symptoms in schizophrenia
12. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance
13. Gender and the expression of schizophrenia
14. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures
15. Causes and consequences of the gender difference in age at onset of schizophrenia
16. Deficit syndrome in older schizophrenic patients
17. Structural neurolmaging in schizophrenia. An integrative view of neuromorphology
18. Symptom classification of schizophrenia changes with the duration of illness
19. Clinical correlates of postmortem brain changes in schizophrenia: Decreased brain weight and length correlate with indices of early impairment
20. The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance
21. Subtype stability in schizophrenia
22. Positive and negative subtypes of schizophrenia. A study from India
23. Sexual dimorphism, brain morphology and schizophrenia
24. Prediction of outcome in first-episode schizophrenia
25. Factors influencing treatment response and outcome of first-episode schizophrenia: Implications for understanding the pathophysiology of schizophrenia
26. Duration of psychosis and outcome in first-episode schizophrenia
27. The incidence of negative symptoms in early schizophrenia, mania and other psychoses
28. An analysis of the clinical features of familial schizophrenia
29. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia
30. Sex differences in brain morphology in schizophrenia
31. Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder
32. The syndrome scales in the AMDP-system
33. Negative symptoms in chronic schizophrenia. Relationship to duration of illness
34. Gender and short-term outcome in schizophrenia
35. Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia
36. Gender differences in the clinical expression of schizophrenia
37. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients
38. From neuropathology to neurodevelopment
39. Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance